Panel Discussion: Looking at the future of clinical trials in rare diseases: where are we now and where are we headed

Considering advances in trial designs and master protocols
Innovating through technology, digital health tools, AI and machine learning
Expanding collaborations and partnerships
Addressing ethical and diversity challenges
Discussing long-term vision in rare disease therapy development